|
Dear Reader,
Welcome to CPE's October newsletter, filled with exciting updates!
This month's edition is dedicated to all those affected by breast and liver cancer, two devastating diseases impacting millions worldwide. Inside, you’ll find updates on our activities and work throughout October.
Warm regards,
The CPE Team
|
|
|
Highlights from the European Commission’s Conference on Innovative Palliative Care for Cancer Patients
CPE was honoured to attend and play an active role on the steering committee for the European Commission’s conference on Innovative Palliative Care, held in Brussels on Tuesday, 8 October 2024. As part of this effort, we contributed to identifying the speakers for this event and the development of the EU Cancer Mission’s policy brief “Innovative palliative care for people with cancer: sustainable solutions for the future” which lays out six essential recommendations to enhance palliative care.
|
|
|
The Need for Ongoing Focus on Liver Cancer Awareness: An Interview with Beatrice Credi, Head of ELPA’s Brussels Office
This month, we were proud to support the public awareness campaign organised by the European Liver Patients’ Association (ELPA), and we had the honour of interviewing Beatrice Credi, Head of ELPA's Brussels Office.
|
|
|
CPE’s Policy Officer Speaks About the Implementation of the EU HTAR and Explains What This Means for Patients.
In her interview with Pharmaceutiques France, CPE's Policy Officer, Josephine Mosset, was direct in her assessment of the regulation’s shortcomings.
|
|
|
A few words from Violeta Pirana on How Renesansa is Empowering Women Affected by Breast Cancer in Kosovo
In October, we had the pleasure of speaking with Violeta Pirana, founder of Renesansa Kosovo. She shared powerful insights into what this month means for the community and highlighted the impactful work that Renesansa, one of our valued CPE member associations, has done to empower women in Kosovo.
|
|
|
CPE Responds to the European Commission’s Consultation on the EU HTA Regulation’s Joint Scientific Consultations
While CPE welcomes the fourth Implementing Act (IA) on Joint Scientific Consultations (JSC) under Regulation (EU) 2021/2282, we call for the consideration of additional steps ensuring meaningful and sustainable patient engagement in the HTA process.
|
|
|
Breaking Barriers in Clinical Trials: Highlights from the Act EU Multi-Stakeholder Platform Annual Meeting
On 22 October 2024, CPE’s Director of Research and Patient Engagement, Juan Ventura spoke at the third session of the Act EU MSP Annual Meeting, and delivered an insightful presentation on “The Future in Oncology Clinical Trials: A Patient Perspective.”
|
|
|
Webinar on "Enhancing Patient Involvement in Personalised Medicine: Lessons from Nigeria, Hungary and Perspective from Europe"
During a lively webinar hosted by the EU-AFRICA PerMed Project on the 29th of October 2024, CPE's Research and Patient Engagement Director, Juan Ventura, shared insights on advancing patient involvement and fostering shared decision-making to enhance care and improve health outcomes.
|
|
|
OnHome Alliance Launch Event
At the launch event of the OnHome Alliance on the 29th of October, 2024, CPE’s Policy Officer, Joséphine Mosset, joined key health stakeholders to emphasise the importance of online prescription access, explaining how this initiative holds the potential to enhance equity, support treatment adherence, and improve patient safety, particularly for cancer patients in remote areas across Europe.
|
|
|
Celebrating 50+ members!
We are excited to announce that CPE has reached 53 members across 26 countries in Europe and the USA! A big THANK YOU to all those cancer patient associations and advocates who trusted us and joined CPE.
Discover our Members Map here.
|
|
|
Join us to discuss equitable access to personalised cancer care at the "Advancing the Precision Oncology Agenda in the EU" Event
CPE is proud to support this event, organised by the European Federation of Pharmaceutical Industries and Associations (EFPIA) with the scientific coordination of the European Regional and Local Health Authorities (EUREGHA), which will be hosted by the European Committee of the Regions on 13 November 2024, from 9:00 to 12:30. Our CEO, Antonella Cardone, will take the stage as a keynote speaker to address the important issues of patient expectations and equitable access, underscoring the need for all patients in Europe to benefit from advancements in oncology.
|
|
|
Keeping the Cancer Momentum Going
We’re still calling for endorsements to eradicate cancer care inequalities across the EU. Join us in making cancer a priority for the European Health Semester by endorsing our manifesto and demanding action from policymakers. Your voice can make a difference!
For more information on the European Health Semester Manifesto launched by CPE and CECOG, visit our website.
If you wish to endorse the manifesto, please fill in this form.
|
|
|
|
|
